← All trials
NCT00198718
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 1997
- Primary completion
- May 1, 2001
- Completion date
- May 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 28220
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Johns Hopkins UniversityLead sponsor
- Academy for Educational Development, Washington DC.Collaborator
- Johns Hopkins UniversityOverall official - principal investigator
- University of ZimbabweCollaborator
- Harare City Health Department, Harare, ZimbabweCollaborator
- Bill and Melinda Gates FoundationCollaborator
- Rockefeller FoundationCollaborator
- BASFCollaborator
- United States Agency for International DevelopmentCollaborator
- McGill UniversityCollaborator
- Johns Hopkins UniversityReponsible party - principal investigator
- University of MontrealCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.